| Product Name: | Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP |
| Brand Name: | Generic |
| Strength: | 5 mg + 10 mg, 2.5 mg + 4 mg |
| Dosage Form: | Tablet (Film coated) |
| Route of Administration: | Via Oral route |
| Packing: | 15s, 30s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Anti-allergic, Anti-histaminic and Anti-asthmatic |
| Indication: | To treat sneezing, runny nose and watery eyes. |
| Storage: | Store below 30°C. |
Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP Technical Specification:
GENERIC NAME OF THE MEDICINAL PRODUCT:
Levocetirizine and Montelukast Tablets IP 5 mg + 10 mg
Levocetirizine and Montelukast Tablets IP 2.5 mg + 4mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A. Levocetirizine and Montelukast Tablets IP 5 mg + 10mg
Each Film Coated Tablet Contains:
Levocetirizine Hydrochloride IP.…….5 mg
Montelukast Sodium IP
eq. to Montelukast ………………….10 mg
Excipients …………………………….…. Q.S.
Colour: Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
To treat the symptoms of Chronic Urticaria, Obstructive Airway Diseases, Chronic Asthma and Rhinitis.
CAUTION & SCHEDULE:
CAUTION :
Keep out of reach of children.
SCHEDULE:
Schedule H Prescription Drug: Warning: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Storage: Protect from light & moisture, at a temperature not exceeding 30 ˚C.
Dosage: As directed by the Physician.